Constraint-weighted rare variant load contributes measurably to cognitive and neuropsychiatric outcomes in population cohorts, particularly among people with autism spectrum disorder and related conditions.
Abstract
Rare protein-truncating variants (PTVs) and damaging missense variants in constrained genes are enriched among people with autism spectrum disorder (ASD), schizophrenia and related conditions, but most studies used clinical cohorts. In European-ancestry participants of the Adolescent Brain Cognitive Development Study (ABCD, 3,523 children) and the All of Us Research Program (AoU, 302,421 adults), we summed, separately for rare PTVs and damaging missense variants, the selection coefficients of affected genes into genetic loads (GLs). In ABCD, one additional typical constrained gene with a PTV was associated with 0.22 SD lower cognition and with ASD (odds ratio 1.80). In AoU, it was associated with ASD (1.34), schizophrenia (1.51) and intellectual disability (ID, 2.02). Missense GL showed smaller, concordant associations. Risk rose with gene constraint, to almost ninefold odds of ID in the most constrained genes, and carriers of a constrained PTV (12% of AoU participants) made up 31% of ID, 20% of schizophrenia and 17% of ASD cases. GL was essentially uncorrelated with polygenic scores. In African-ancestry participants, PTV GL retained 71-125% of its European-ancestry effect, versus 23-62% for matched polygenic scores. Constraint-weighted rare variant load contributes measurably to cognitive and neuropsychiatric outcomes in population cohorts.
This study finds that rare variants across hundreds of genes contribute to autism with variable phenotypic outcomes, and clusters them based on association evidence from large-scale studies of developmental disorders, schizophrenia, bipolar disorder, and epilepsy.
F. Satterstrom, C. Auwerx, J.-M. Fu et al.· medRxiv· 1 citation
Combining within-case genome-wide association studies with xWAS nominates candidate genes mediating common-variant effects on ASD heterogeneity, provides biological insight, and suggests candidates for phenotypically stratified drug repositioning.
C. Marinelli, A. Amaolo, D. Marnetto et al.· medRxiv· 0 citations
Clinical cohort findings that rare monoallelic LoF variants in ZNF536 underlie a genetic neurodevelopmental disorder characterized by developmental delay, autism, and behavioral dysregulation support a role for ZNF536 as a dosage-sensitive regulator of cortical development.
S. Hiatt, Wen-Jing Zhao, Zhong-Qing Wang et al.· American Journal of Human Ge...· 0 citations
This first whole-exome study of schizophrenia in the Indigenous Mizo population provides preliminary evidence of increased rare damaging coding-variant burden and negative-symptom severity, supporting the involvement of synaptic and neurodevelopmental disturbances in an underrepresented Indigenous population.
Ramdintluangi, H. Lalremmawia, C. Lalhrekima et al.· Asian Journal of Psychiatry· 0 citations
A Kazakhstani family with 9-year-old monozygotic twin girls who developed focal seizures with secondary generalization at approximately one year of age and were subsequently diagnosed with ASD is described, illustrating the distinction between candidate variants and a molecular diagnosis.
A. Gabdulkayum, Z. Mirmanova, A. Daniyarov et al.· Eurasian journal of applied...· 0 citations
This study provides the first comprehensive genomic overview of ASD in a large Brazilian cohort, reinforcing the critical need to include diversely admixed populations in genomic research to expand the understanding of ASD architecture and improve diagnostic strategies in resource-limited settings.
Gabriele da Silva Campos, C. I. S. Costa, J. Wang et al.· Genetics and Molecular Biolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.